Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

SRx Health Solutions (SRXH) Return on Sales (2016 - 2025)

SRx Health Solutions' Return on Sales history spans 10 years, with the latest figure at 0.57% for Q3 2025.

  • For Q3 2025, Return on Sales fell 71.0% year-over-year to 0.57%; the TTM value through Sep 2025 reached 0.57%, down 30.0%, while the annual FY2024 figure was 0.33%, 92.0% up from the prior year.
  • Return on Sales reached 0.57% in Q3 2025 per SRXH's latest filing, up from 1.47% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 2.25% in Q2 2021 to a low of 2.63% in Q4 2022.
  • Average Return on Sales over 5 years is 0.49%, with a median of 0.29% recorded in 2023.
  • Peak YoY movement for Return on Sales: surged 351bps in 2021, then plummeted -252bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.46% in 2021, then plummeted by -468bps to 2.63% in 2022, then grew by 2bps to 2.58% in 2023, then skyrocketed by 92bps to 0.21% in 2024, then crashed by -177bps to 0.57% in 2025.
  • Per Business Quant, the three most recent readings for SRXH's Return on Sales are 0.57% (Q3 2025), 1.47% (Q2 2025), and 0.13% (Q1 2025).